SCHEMBL25899645

SCHEMBL25899645

CCN1C(=O)C(C)(C)c2ccc(C(C)(C)C)nc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MARK3 P27448 2/20 0.48
AURKA O14965 2/20 0.33
AURKB Q96GD4 2/20 0.33
ELANE P08246 2/20 0.32
ALDH1A1 P00352 1/20 0.32
PKM P14618 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PGR P06401 1/20 0.31
F2 P00734 1/20 0.31
CTSG P08311 1/20 0.31
CTRC Q99895 1/20 0.31
CHEK1 O14757 1/20 0.30
SRC P12931 1/20 0.30
CDK2 P24941 1/20 0.30
KDR P35968 1/20 0.30
FLT3 P36888 1/20 0.30
GSK3B P49841 1/20 0.30
BACE1 P56817 1/20 0.30
BACE2 Q9Y5Z0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25898322 0.79 MARK3 (0.50) MARK3AURKAAURKBELANEALDH1A1
SCHEMBL25899947 0.79 MARK3 (0.50) MARK3AURKAAURKBELANEPGR
SCHEMBL25888905 0.77 MARK3 (0.48) MARK3AURKAAURKBELANEPGR
SCHEMBL22693085 0.72 ALDH1A1 (0.37) ELANEALDH1A1KMT2AF2CTSG
SCHEMBL22402392 0.71 ATAD2 (0.41) ELANEF2CTSGCTRC
SCHEMBL17275707 0.65 ALDH1A1 (0.47) MARK3AURKAAURKBALDH1A1PKM
SCHEMBL9202873 0.63 GPR55 (0.56) MARK3ELANEALDH1A1KMT2ASMN1; SMN2
SCHEMBL5543415 0.63 CYP2C9 (0.49) AURKAAURKBALDH1A1PKMKMT2A
SCHEMBL4507178 0.62 CYP1A2 (0.46) AURKAAURKBALDH1A1KMT2A
SCHEMBL4501318 0.62 ATAD2 (0.44) MARK3AURKAAURKBELANEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023138362-A1 WEE1 INHIBITOR, PREPARATION THEREFOR, AND USE THEREOF 江苏天士力帝益药业有限公司 2023-07-27 WO disclosed